You are here

Ishwaria Subbiah (US)

Cancer remains a disease that disproportionately affects older people. Despite accounting for the greatest proportion of those with cancer, older patients represent a significantly lower proportion of patients included in clinical trials. The care of older adults with cancers calls for a substantial understanding of the intricacies of supportive care and geriatrics, oncology as well as phase I/II clinical trial design. Dr. Subbiah is uniquely qualified for this role, having acquired this essential knowledge through her training at MD Anderson first as a Fellow in the Department of Investigational Cancer Therapeutics (A Phase I Program), then in Medical Oncology in the Division of Cancer Medicine and most recently in Department of Palliative, Rehabilitation, and Integrative Medicine. Dr. Subbiah has a thorough understanding of phase I and II clinical trial design, novel therapeutics including immunotherapy and targeted therapies, fundamentals of medical oncology practice and symptom management. With this robust foundation, she cultivates a clinical practice and research focus on symptom management in all patients with particular emphasis on the older adults.

November 18, 2018
2:00pm to 3:30pm Emerging technologies in diagnosis and care Breakout room Esther Bastiaannet (NL), Ishwaria Subbiah (US), Nienke de Glas (NL), Daniël Souwer (NL), Romain Corre (FR), Tina Hsu (CA), Aldo Dettino (BR)